VB-Link Oncology City Challenge Successfully Concludes with 19 Projects Competing for Three Major Awards
On June 10, 2023, the VB-Link Future Healthcare Specialty Innovation Solutions Challenge – Oncology City Round was successfully held at Fosun Tech Park in Shanghai! The event brought together 19 oncology projects from fields such as biopharmaceuticals, medical devices, digital health, and healthcare services for sequential roadshows, competing for three major awards: Most Commercially Valuable Award, Most Innovative Potential Award, and Best Development Exploration Award!
Throughout years of medical advancement, innovation has driven continuous transformation in oncology treatment. Against this backdrop, the Future Medical Specialty Innovation Solutions Challenge (VB-Link Competition) was launched. The VB-Link Oncology City Competition received registrations from over 35 oncology projects, with 19 advancing to the city-level round. Participants included hospital professors, research institute scientists, and leading industry talents, alongside high-quality innovative cases from prestigious universities such as Peking University. The projects advancing to the city competition covered a diverse range of cutting-edge fields, including early cancer diagnosis and screening, AI-driven drug discovery, cell therapy, and organoid disease models.
The competition attracted a total of 11 distinguished judges, including clinical experts and scholars from the Cancer Hospital of the Chinese Academy of Medical Sciences, Shanghai Cancer Institute, Zhongshan Hospital Fudan University, and Huashan Hospital Fudan University; representatives from institutions such as the Shanghai “Regional TTO” Platform and Suzhou Medical Device Innovation Center; and investors from Fosun Star Future, Fosun Health Capital, Hetang Venture Capital, and Chuangrui Investment.
At the outset of the competition,General Manager, Henlius Shanghai Innovation Center、Dr. Shan Yongqiang, Partner of the Fosun Science and Technology Innovation CommitteeDelivering the opening remarks, Shan Yongqiang shared his insights on innovation and his expectations for the future of innovation in China’s healthcare industry, affirming the significance of this Oncology Challenge for driving innovation across the entire healthcare sector.
Dr. Shan Yongqiang, General Manager of Henlius Shanghai Innovation Center and Partner of Fosun Science and Technology Innovation Committee
Immediately following, inBi Yuanfeng, Co-founder and COO of VCBeatUnder the moderation of VCBeat, representatives from each participating project delivered compelling pitch presentations. A panel of 11 senior experts and leading figures from the oncology industry served as judges, evaluating the projects across six dimensions: completeness of the business plan, team background, project innovation, market operations, distinctive advantages, and on-site Q&A performance, thereby providing professional insights for both the competition and the projects. Ultimately, the awards were granted to six projects for the “Most Commercially Valuable Award,” seven for the “Most Innovative Exploration Award,” and six for the “Most Promising Potential Award.” Among these, the six projects and teams that received the “Most Commercially Valuable Award” successfully advanced to the VB-Link Competition Grand Finals.
The VB-Link Future Healthcare Specialty Innovation Solutions Challenge is organized by VB100 and VCBeat, co-organized by Zhongguancun Development Group and the Administrative Committee of Tianjin Binhai–Zhongguancun Science Park, and co-supported by institutions such as Furong Laboratory and the Intellectual Property Center of Central South University. It has also received strong support from nearly 40 leading venture capital firms, multinational corporations, and innovation centers.
The inaugural competition featured four specialty tracks: ophthalmology, neurology, cardiology, and oncology. City-level heats were held successively in Beijing, Shanghai, Tianjin, and Hangzhou, culminating in the grand finale in Tianjin on June 28. The Cardiology Specialty Challenge is scheduled to take place in Tianjin on June 15—stay tuned!
Scan the QR code in the image to learn more about upcoming event details.
Star Future Institute (hereinafter referred to as “Star Future”) is an entrepreneurship service platform under Fosun. Adopting a trinity model of “investment + training + incubation,” it aims to build a novel entrepreneurship service platform that aggregates high-quality medical service resources and focuses on healthcare and frontier technological innovation. Star Future operates three core business segments: entrepreneurship training, an innovation center, and an investment fund. It seeks to better amplify Fosun’s influence in sci-tech innovation and public welfare, bridge internal and external ecosystems, gather scientific research talent, projects, and pipelines, and establish collaborative partnerships between Fosun and research institutions, universities, and policymakers.
The Future Healthcare Achievement Transformation and Cooperation Conference (VB-Link Conference) is a premier industry event in China, initiated by VCBeat and VB100. Market-demand driven, it focuses on sharing cutting-edge insights, showcasing achievements, and facilitating matchmaking and collaboration for the translation of medical science and technology outcomes. The conference features diverse content, including the Future Healthcare Specialty Innovation Solutions Competition (VB-Link Competition), the VB-Link Award series, White Papers on Clinical Pain Points, and a series of themed summits.
The VB-Link Future Healthcare Achievement Transformation and Cooperation Conference, along with the Grand Finals of the VB-Link Future Healthcare Specialty Innovation Solutions Challenge, will be officially held from June 28 to 29, 2023. A total of 24 high-quality projects across four medical specialties will converge in Tianjin for a compelling showcase at the InterContinental Tianjin Yujiapu Hotel. The event will bring together government officials, industry experts, research leaders, entrepreneurial elites, and prominent healthcare investors. Stay tuned!
